![Hartmut Juhl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hartmut Juhl
Algemeen Directeur bij Indivumed GmbH
Profiel
Hartmut Juhl is the founder.
He founded Indivumed GmbH in 2002 and currently holds the title of Chief Executive Officer.
In addition to his founding position, Dr. Juhl also worked as an Associate Professor at Georgetown University.
He obtained a doctorate degree from the University of Hamburg.
Actieve functies van Hartmut Juhl
Bedrijven | Functie | Begin |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Algemeen Directeur | 01-04-2002 |
Eerdere bekende functies van Hartmut Juhl
Bedrijven | Functie | Einde |
---|---|---|
Georgetown University | Corporate Officer/Principal | - |
Opleiding van Hartmut Juhl
University of Hamburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |